Ray Wang

Ray (Yu) Wang is a seasoned professional in the pharmaceutical industry with extensive experience in drug product development. Currently serving as Director of Injectable Drug Product Development at Alexion Pharmaceuticals, Inc., Ray has previously held pivotal roles such as Associate Director in MS&T Drug Product for Gene Therapy at PTC Therapeutics, and several significant positions at Bristol Myers Squibb, including Senior Principal Scientist. With a foundational background at Celgene and Eli Lilly focusing on biologics drug product development and formulation, as well as postdoctoral research at The University of Kansas and NIH emphasizing macromolecule stabilization and protein NMR methodology, Ray holds a Ph.D. in Biochemistry and Biophysics from The University of Kansas and a B.S. in Biology from the University of Science and Technology of China.